DeepHealth (formerly Kheiron Medical Technologies)
About DeepHealth (formerly Kheiron Medical Technologies)
DeepHealth, formerly Kheiron Medical Technologies, is a healthcare AI company focused on empowering breakthroughs in care through imaging. As a wholly-owned subsidiary of RadNet, Inc., DeepHealth provides AI-powered health informatics solutions designed to enhance operational efficiency and improve clinical outcomes across various areas, including breast, chest, musculoskeletal, neuro, prostate, and thyroid health. Their portfolio includes an AI-powered, cloud-native operating system, DeepHealth OS, which unifies data across clinical and operational workflows and personalizes AI-powered workspaces for radiologists. The company’s solutions are utilized by thousands of imaging centers and radiology departments globally to enable earlier, more reliable, and more efficient disease detection, particularly in large-scale cancer screening programs.
For physicians, DeepHealth offers a comprehensive suite of AI-powered tools aimed at streamlining diagnostic workflows and improving diagnostic accuracy. Their Breast Suite, for example, provides enhanced workflow and diagnostic accuracy in breast cancer detection, with studies demonstrating increased cancer detection rates. The company also offers solutions like the Diagnostic Suite™ for a unified diagnostic workspace with PACS functionality and advanced image management, and the Operations Suite™ for smart operations with RIS functionality and real-time workflow management. DeepHealth’s commitment to clinical rigor is evident in their extensive clinical studies, which aim to prove the effectiveness and safety of their AI solutions across diverse patient populations and equipment. DeepHealth’s offerings are designed to address challenges such as workforce constraints, rising imaging volumes, and the need for consistent, high-quality diagnostic pathways, ultimately enabling healthcare systems to move from reactive treatment to proactive intervention.
What Physicians Need to Know
For physicians, DeepHealth's AI tools aim to enhance diagnostic accuracy and consistency, enabling earlier disease detection and more proactive intervention. The Breast Suite, for example, has shown a significant increase in breast cancer detection rates, even in dense breasts and diverse patient populations, and can elevate the performance of generalist radiologists to the level of specialists. The AI-powered solutions also streamline workflows, automate tedious tasks like nodule detection and reporting in thyroid imaging, and provide risk assessments, ultimately leading to improved operational efficiency and patient outcomes. The TechLiveu2122 platform can also help overcome staffing challenges and expand access to advanced imaging procedures through remote scanning and management.
DeepHealth's solutions are designed to be cloud-native or hybrid platforms, simplifying deployment and operations. Their DeepHealth OS unifies data across clinical and operational workflows, and they actively work with leading OEMs, cloud, AI, and platform partners to integrate fragmented tools into a connected, end-to-end imaging experience. They also integrate with existing thyroid imaging workflows and technology. DeepHealth's AI Studio Suite orchestrates over 140 AI algorithms from more than 75 ecosystem partners within the clinical workflow, including the worklist, viewer, reporting modules, and workflow engine.
What the Web Says
DeepHealth, formerly Kheiron Medical Technologies, is an AI diagnostics company focused on transforming cancer care, particularly breast cancer screening. Their flagship product, Mia (Mammography Intelligent Assessment), uses deep learning to analyze mammograms, aiming to improve detection accuracy and efficiency for radiologists. The company has expanded its AI portfolio to include solutions for prostate, chest, neuro, and thyroid imaging, and operates as a subsidiary of RadNet.
Overall: MixedStrengths
- AI-powered solutions show promising results in improving early breast cancer detection and overall screening outcomes, potentially detecting more cancers and reducing unnecessary recalls.
- Mia has European regulatory approval to act as an independent second reader in double-reading programs, a significant breakthrough in AI diagnostics.
- The technology can help reduce the workload for radiologists and improve efficiency in reporting.
- DeepHealth's solutions are designed to integrate with existing healthcare systems and offer end-to-end AI-powered solutions for large-scale diagnostic and screening programs.
- The company fosters a collaborative environment with a close-knit, growing team.
- DeepHealth is expanding its portfolio and global reach through strategic acquisitions and partnerships.
Limitations
- Some employer reviews, potentially related to its parent company RadNet, mention issues like being overworked, poor pay, toxic micromanagement, and a lack of opportunities for quick advancement or innovation.
- Compensation and benefits for knowledge workers and doctors may use the same model as for imaging center staff with high turnover, leading to fewer recognized holidays compared to industry standards.
- One intern review mentioned that the work wasn't always aligned with their interests or competencies, particularly regarding Python or cloud computing.
- Concerns remain about AI's generalization across heterogeneous deployment environments with different population groups and mammography equipment vendors.
- The company's focus on building partnerships and development within the medical industry, rather than sales in crypto, might be seen as a drawback by some in the crypto community (referring to DeHealth, a different company with a similar name).
Based on reviews from: AuntMinnie, Indeed.com, Handshake, RadNet, Forbes, AI Magazine, Reddit, PMC, G2
Last updated: 2026-06-21
Videos
News, demos, and interviews about DeepHealth (formerly Kheiron Medical Technologies).
Videos load interactively. If none appear, search YouTube for DeepHealth (formerly Kheiron Medical Technologies) →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]